Skip to main content
Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.970
+0.150 (8.24%)
At close: Mar 9, 2026, 4:00 PM EDT
1.999
+0.029 (1.47%)
After-hours: Mar 9, 2026, 7:22 PM EDT

Caribou Biosciences Revenue

In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth. Caribou Biosciences had revenue of $3.94M in the quarter ending December 31, 2025, with 89.74% growth.

Revenue (ttm)
$11.16M
Revenue Growth
+11.66%
P/S Ratio
17.06
Revenue / Employee
$75,912
Employees
147
Market Cap
190.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202511.16M1.17M11.66%
Dec 31, 20249.99M-24.48M-71.01%
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Arcturus Therapeutics Holdings 82.03M
Compugen 72.76M
ProQR Therapeutics 18.86M
Whitehawk Therapeutics 14.38M
Molecular Partners AG 856.30K
SAB Biotherapeutics 114.70K
NeOnc Technologies Holdings 59.99K
Revenue Rankings

CRBU News

More News